879551-01-6

Basic information

• Product Name: (4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide
• Synonyms: (4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide
• CAS NO: 879551-01-6
• Molecular Weight: 310.325
• Mol File: 879551-01-6.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: (4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: (4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide(879551-01-6)
• EPA Substance Registry System: (4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide(879551-01-6)

Safety Data

• Hazardous Substances Data: 879551-01-6(Hazardous Substances Data)

Usage

General Description

The chemical compound "(4S,5R)-ethyl 5-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-4-Methyl-1,3,2-dioxathiolane-4-carboxylate 2,2-dioxide" is a complex organic molecule with a unique and specific structure. It contains both sulfur and oxygen atoms, along with a series of carbon and hydrogen atoms. The presence of dioxolan and dioxathiolane functional groups in its structure indicates that it may have potential applications in pharmaceuticals, agrochemicals, or other organic synthesis processes. The compound's stereochemistry and chiral centers suggest that it may possess interesting and potentially valuable properties for use in various chemical and biological processes.

Upstream product

• 81997-76-4 (S,E)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-methylpropionic acid ethyl ester 
• 130606-67-6 C₁₁H₁₈O₄ 
• 15186-48-8 2,3-isopropylidene-glyceraldehyde 
• 21382-82-1 (carbethoxyethylidene)triphenylphosphorane 
• 93635-76-8 (2S,3R)-3-[(4R)-2,2-dimethyl-[1,3]dioxolane-4-yl]-2,3-dihydroxy-2-methylpropionic acid ethyl ester 
• 1020063-91-5 C₁₁H₁₈O₇S 

Downstream Products

• 1596350-90-1 C₂₂H₂₄N₄O₃ 
• 1596350-94-5 C₂₃H₂₆N₆O₃ 
• 1596350-95-6 C₂₅H₂₆N₈O₃ 
• 1403574-26-4 C₂₀H₁₇N₃O₆ 
• 1596350-41-2 C₂₀H₂₁N₃O₄ 
• 1596350-43-4 C₂₇H₂₈N₆O₃S 
• 1596350-44-5 C₂₆H₂₇N₇O₃ 
• 1496551-77-9 C₂₂H₂₉ClN₃O₉P 
• 1496551-70-2 2'-deoxy-2'-chloro-2'-C-methyl-3',5'-di-O-benzoyl-N⁴-benzoylcytidine 
• 1613589-83-5 C₆₈H₆₉F₂N₆O₁₀P 
• 1496551-72-4 1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 

Relevant articles and documents

BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E

The present disclosure is directed toward bi- and monocyclic nucleoside analogs, and compositions comprising these compounds for use in the treatment of hepatitis E infections.

METHOD FOR PRODUCING CYCLIC SULFATE

PROBLEM TO BE SOLVED: To provide an efficient method for producing a cyclic sulfate that is useful as an intermediate for pharmaceuticals and agrochemicals. SOLUTION: The cyclic sulfate can be produced by reacting a starting material, 1,2-diols, with sulfuryl halide in the presence of an inorganic base. Further, it was favorably found that by reacting sulfuryl halide to 1,2-diols under specific conditions, the target material of the present invention, the cyclic sulfate, can be isolated in high selectivity. The present invention enables production of a cyclic sulfate, which has been a little difficult to isolate, in high productivity by one step by a simple work. SELECTED DRAWING: None COPYRIGHT: (C)2017,JPOandINPIT

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.